UCL Researchers Discover Method to Enhance Immune Detection of Cancer Cells by Targeting Nonsense-Mediated mRNA Decay

Researchers at University College London (UCL) have identified a new method to make cancer cells more detectable by the immune system, potentially advancing the field of cancer immunotherapy. The team focused on a cellular process called Nonsense-Mediated mRNA Decay (NMD), which plays a key role in quality control within cells. By targeting this mechanism, scientists uncovered an unexpected vulnerability in tumor cells that could be exploited for therapeutic purposes.

The study highlights how manipulating NMD can expose cancer cells to immune detection. NMD typically functions to eliminate faulty mRNA molecules, preventing the production of abnormal proteins. However, researchers found that interfering with this process in cancer cells can lead to the accumulation of specific proteins that signal their presence to the immune system. This discovery opens up possibilities for developing treatments aimed at enhancing immune responses against tumors by leveraging this newly identified weakness in cancer biology.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 8, 2026

Author

GOAI